Evidence map›Paper›PMID 38797976›Full record

ReviewAging cell2024

Translatability of life-extending pharmacological treatments between different species.

Daiana Burdusel, Cristin Coman, Diana-Larisa Ancuta, Dirk M Hermann, Thorsten R Doeppner, Andrei Gresita, Aurel Popa-Wagner

Abstract readReview
In one paragraph

Review in Aging cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Genetic and Epigenetic Interactions Involved in Senescence of Stem Cells.International journal of molecular sciences · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daiana BurduselDoctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Cristin ComanCantacuzino National Medical Military Institute for Research and Development, Bucharest, Romania.
Diana-Larisa AncutaCantacuzino National Medical Military Institute for Research and Development, Bucharest, Romania.
Dirk M HermannChair of Vascular Neurology and Dementia, Department of Neurology, University Hospital Essen, Essen, Germany.
Thorsten R DoeppnerDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Andrei GresitaDepartment of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, New York, USA.
Aurel Popa-WagnerDoctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania.ORCID 0000-0003-4574-8605

Funding

European Union 760058Executive Agency for Higher Education, Research, Development and Innovation Funding PN-III-P4-ID-PCE-2020-059German Federal Ministry of Education and Science 161L0278B (3DOS)German Research Foundation 514990328
6 · The paper itself

Abstract

Anti-aging research has made significant strides in identifying treatments capable of extending lifespan across a range of organisms, from simple invertebrates to mammals. This review showcases the current state of anti-aging interventions, highlighting the lifespan extensions observed in animal models through various treatments and the challenges encountered in translating these findings to humans. Despite promising results in lower organisms, the translation of anti-aging treatments to human applications presents a considerable challenge. This discrepancy can be attributed to the increasing complexity of biological systems, species-specific metabolic and genetic differences, and the redundancy of metabolic pathways linked to longevity. Our review focuses on analyzing these challenges, offering insights into the efficacy of anti-aging mechanisms across species and identifying key barriers to their translation into human treatments. By synthesizing current knowledge and identifying gaps in translatability, this review aims to underscore the importance of advancing these therapies for human benefit. Bridging this gap is essential to assess the potential of such treatments in extending the human healthspan.

Indexed as

LongevityAgingAnimalsCaenorhabditis elegansChloroquineDrosophila melanogasterMetforminMiceResveratrolSaccharomycesSirolimusSpecies SpecificitySpermidineChloroquineMetforminResveratrolSirolimusSpermidineagingdrug treatmentshumansinvertebrateslifespantranslatabilityvertebrates

Identifiers

PMID38797976
PMCPMC11258477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.